HealthMore in Health→
Microbiome Therapy Cuts Infections in Early Transplant Trial
Key Takeaways
- SER-155 contains 16 selected beneficial bacterial strains.
- The phase 1 trial reported no treatment-related side effects.
- Recipients had fewer bloodstream infections and lower levels of harmful bacteria.
DE
DT Editorial Team··via medicalxpress.com
